[Summary] Committed to the development of high-quality human vaccines and therap
Company Profile:
Suzhou Weichao Biotechnology Co., Ltd. is located in Sangtiandao Biopharmaceutical Industrial Park, Suzhou Industrial Park, and is committed to the development of high-quality human vaccines and therapeutic products. The company currently has a 2,000 m² R&D laboratory and a 6,000 m² pilot plant, equipped with internationally advanced experimental equipment. It has a mature technology system focusing on bacterial polysaccharide-protein conjugate vaccines, DTP series combination vaccines, and recombinant protein vaccines. It possesses a full set of experience ranging from preclinical research, pilot-scale research, clinical filing, scale-up and production, to quality management, and will build a first-class vaccine R&D team in China in the future.
Taking the realization of Healthy China as its mission, Weichao Biotech uses new knowledge and new technologies to improve the clinical efficacy and value of vaccine products; from an international perspective, it develops vaccines and therapeutic products for clinically difficult-to-control diseases, and develops into an enterprise integrating research, development, production, and sales that has both product innovation capability and the ability to solve existing clinical problems of current vaccines, leading domestic vaccine development and helping Healthy China with high-quality vaccines.
Entrepreneurial Team:
1. Possesses decades of experience in the vaccine industry, is proficient in industry strategic layout, and has rich operational management experience.
2. Has completed the R&D and transfer to production of 2 marketed new drugs, completed Phase II or Phase III clinical studies of multiple vaccines, and led or undertaken more than 10 National Science and Technology Major Projects and "863" projects; consists of returnees from well-known foreign universities and pharmaceutical companies and senior technical personnel from domestic vaccine enterprises.
3. Has study experience at multiple well-known research institutions and universities in North America and Europe, and has good cooperative relationships with experts from these institutions, some of whom serve as the company's technical advisors.
Corporate Culture:
Unity: Build a cohesive and united R&D team.
Pragmatism: A down-to-earth, hard-working attitude.
Technology: Develop new processes and upgrade production methods.
Innovation: Strive to be the first in China or the first in the world.
Development Advantages:
Team advantage: The core team has rich experience in bacterial vaccine R&D, a deep understanding of existing vaccine manufacturing and problems, possesses a full set of conjugate vaccine quality control methods, and its evaluation methods are aligned with international standards.
Technical advantage: Possesses a bacterial scale-up culture and purification technology system, conjugate vaccine technology system, molecular biology technology system, quality control and vaccine evaluation technology system.
Cooperation advantage: Has formed a Strategic Development Department with well-known domestic experts, has international and domestic renowned scholars participating in R&D guidance, and carries out multi-organization, multi-center experimental research and cooperation.
Concept advantage: Closely follows international cutting-edge technologies; replaces traditional production methods; cultivates and builds talent teams; closely combines immediate footing with long-term development.
Promotion Channels
Technical channel: Assistant Engineer, Engineer, Senior Engineer, Chief Engineer
Management channel: Assistant Engineer, Engineer, Supervisor, Deputy Manager (Assistant to Project Leader, Deputy Director), Manager (Project Leader, Director)
Company Benefits:
1. Provide an industry-competitive compensation mechanism and incentive mechanism.
2. Benefits include: meal allowance, transportation allowance, communication allowance, high-temperature allowance, holiday benefits, annual health check, paid annual leave, five social insurances and one housing fund, and supplementary accident insurance.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows